Dr. Kelly is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
146 West River Street
3rd Floor
Providence, RI 02904Phone+1 401-793-5700Fax+1 401-793-7801- Is this information wrong?
Summary
- Dr. Colleen Kelly is a gastroenterologist in Providence, RI and is affiliated with Miriam Hospital. She received her medical degree from The Ohio State University College of Medicine and has been in practice 18 years. She is experienced in general gastroenterology and inflammatory bowel disease.
Education & Training
- Brown UniversityFellowship, Gastroenterology, 2003 - 2006
- Boston University Medical CenterResidency, Internal Medicine, 1999 - 2002
- Ohio State University College of MedicineClass of 1999
Certifications & Licensure
- MA State Medical License 2001 - 2026
- RI State Medical License 2005 - 2024
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
Clinical Trials
- Fecal Transplant for Relapsing C. Difficile Infection Start of enrollment: 2012 Oct 01
- Safety of FMT: OpenBiome Outcomes and Longitudinal Follow-up (STOOL) for Recurrent Clostridium Difficile Infection Start of enrollment: 2015 Mar 01
- SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI) Start of enrollment: 2015 May 01
- Join now to see all
Publications & Presentations
PubMed
- Outcomes after Fecal Microbiota Transplantation in combination with Bezlotoxumab for Inflammatory Bowel Disease and Recurrent C . difficile Infection.Jessica R Allegretti, Jordan Axelrad, Rahul S Dalal, Colleen R Kelly, Ari Grinspan, Monika Fischer> ;The American Journal of Gastroenterology. 2024 Mar 19
- Conclusion.Kelly, C.> ;The American Journal of Gastroenterology. 2024 Jan 1
- 2 citationsEfficacy, Safety, and Cost-effectiveness of Bezlotoxumab in Preventing Recurrent Clostridioides difficile Infection : Systematic Review and Meta-analysis.Mouhand F H Mohamed, Christopher Ward, Azizullah Beran, Mohamed A Abdallah, Joseph Asemota, Colleen R Kelly> ;Journal of Clinical Gastroenterology. 2024 Apr 1
- Join now to see all
Press Mentions
- How Gut Bacteria Could Boost Cancer TreatmentsJuly 28th, 2022
- How Gut Bacteria Could Boost Cancer TreatmentsJuly 19th, 2022
- Pill Derived from Human Feces Treats Recurrent Gut InfectionsJanuary 19th, 2022
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Miriam HospitalProvidence, Rhode Island
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: